Bellicum Pharmaceuticals
15 clinical trials · Sponsor
◉ Watch Bellicum Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors (NCT04650451) | Bellicum Pharmaceuticals | 2020-12-07 |
| Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (NCT03699475) | Bellicum Pharmaceuticals | 2018-12-27 |
| Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant (NCT03459170) | Bellicum Pharmaceuticals | 2018-02-01 |
Track Bellicum Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.